Ecolab (ECL)
(Delayed Data from NYSE)
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Zacks News
DexCom's (DXCM) G6 CGM System Combines With AID in Netherlands
by Zacks Equity Research
DexCom (DXCM) announces expansion of its AID partnership in the Netherlands to offer an easier diabetes management experience.
Dow (DOW) Acquires Circulus to Boost Circular Economy Efforts
by Zacks Equity Research
Dow (DOW) is acquiring Circulus to enhance its materials science and film recycling capabilities, expanding its circular product offerings.
DuPont (DD) & Desun Launch Flexible Solar Panels in Germany
by Zacks Equity Research
DuPont (DD) Tedlar frontsheets have a unique mix of mechanical durability, abrasion resistance, outdoor stability and high light transmittance.
Veeva's (VEEV) Vault EDC to Boost Vita Global's Data Management
by Zacks Equity Research
Veeva's (VEEV) Vault EDC is likely to improve Vita Global's clinical data management processes.
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
by Zacks Equity Research
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.
Venus Concept's (VERO) Latest Supply Deal to Aid its Business
by Zacks Equity Research
Venus Concept (VERO) announces an exclusive strategic supply arrangement with Skin Laundry Holdings, Inc.
B2Gold (BTG) Provides Upbeat Assessment Results for Gramolate
by Zacks Equity Research
B2Gold (BTG) announces the latest preliminary economic assessment results for the Gramalote project indicating an average yearly production of 185,000 ounces of gold over a 12.5-year life.
Universal Stainless (USAP) Rallies 78% in 6 Months: Here's Why
by Zacks Equity Research
Solid first-quarter performance on the back of the strength in aerospace contributes to the rally in Universal Stainless' (USAP) shares.
BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold
by Zacks Equity Research
BrainsWay's (BWAY) latest exclusive multi-year distribution agreement is likely to provide improved patient care in Canada.
Green Plains (GPRE) Updates on Nebraska Carbon Capture Project
by Zacks Equity Research
Green Plains (GPRE) enters into construction agreements and funding arrangements to facilitate the ordering of carbon sequestration equipment.
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
by Zacks Equity Research
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
Energy Fuels (UUUU) Appoints Director to Grow REE Business
by Zacks Equity Research
Energy Fuels (UUUU) appoints Debra Bennethum as the director to grow its rare earth business. It also achieves the commercial production of separated REE at its White Mesa Mill.
Merit Medical (MMSI) Recalls Syringes Made by Jiangsu Shenli
by Zacks Equity Research
Merit Medical (MMSI) recalls certain products containing syringes made by a Chinese manufacturer, Jiangsu Shenli.
U.S. Steel (X) Issues Q2 View, Progresses on Nippon Transaction
by Zacks Equity Research
U.S. Steel (X) anticipates sequentially lower earnings for Q2 and projects EBITDA of $425 million. It continues to advance toward finalizing the Nippon Steel transaction.
Steel Dynamics (STLD) Sees Q2 Earnings to Fall on Lower Pricing
by Zacks Equity Research
Steel Dynamics (STLD) projects second-quarter earnings to decline sequentially, with mixed performance across steel, recycling and fabrication operations.
Are Basic Materials Stocks Lagging DRDGOLD Limited (DRD) This Year?
by Zacks Equity Research
Here is how DRDGOLD (DRD) and Ecolab (ECL) have performed compared to their sector so far this year.
Nutrien (NTR) Prices $1 Billion of 3-Year & 10-Year Senior Notes
by Zacks Equity Research
The senior notes will be unsecured and will rank on an equal footing with Nutrien's (NTR) current senior unsecured debt.
LyondellBasell (LYB) Boosts PP Compounding Production in China
by Zacks Equity Research
The start-up of the new production line marks another milestone in LyondellBasell's (LYB) ongoing commitment to the China market.
GE HealthCare's (GEHC) New Tie-Up to Boost Patient Care in Mexico
by Zacks Equity Research
GE HealthCare's (GEHC) latest agreement is likely to standardize care protocols and improve the quality of CT, MR and ultrasound examinations.
Nucor (NUE) Projects Lower Q2 Earnings Amid Weaker Steel Prices
by Zacks Equity Research
Nucor (NUE) expects second-quarter earnings to decline sequentially and has returned over $1.76 billion to stockholders so far in 2024.
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
by Zacks Equity Research
Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.
DOW Launches Two New REVOLOOP Recycled Plastics Resins
by Zacks Equity Research
DOW plans to transform waste and commercialize 3 million metric tons of circular and green solutions per year by 2030.
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
by Zacks Equity Research
Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.
Smith & Nephew's (SNN) CORIOGRAPH to Aid Arthroplasty Procedure
by Zacks Equity Research
Smith & Nephew (SNN) announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, exclusively for use with the CORI Surgical System.
3 Reasons to Hold Veeva Systems (VEEV) Stock in Your Portfolio
by Zacks Equity Research
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.